Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2026-05-05 @ 5:39 AM
Study NCT ID:
NCT01895335
Status:
COMPLETED
Last Update Posted:
2016-12-06
First Post:
2013-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Sponsor:
Sanofi
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Sclerosis | View |
Keywords: